Publicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (11)

2015

  1. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: Challenges and opportunities

    Clinical Pharmacology and Therapeutics, Vol. 97, Núm. 1, pp. 37-54

2013

  1. A comparative performance test of standard, medium- and high-throughput comet assays

    Toxicology in Vitro, Vol. 27, Núm. 2, pp. 768-773

2011

  1. The influence of scoring method on variability in results obtained with the comet assay

    Mutagenesis, Vol. 26, Núm. 3, pp. 393-399

1997

  1. DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours

    British Journal of Cancer, Vol. 76, Núm. 7, pp. 923-929

1996

  1. 4-Cyano-2-oxo-1,2,4-oxadiazolo[2,3-a]quinoxaline 5-N-oxides. New synthetic method and reaction with alcohols. Potential cytotoxic activity

    Journal of Heterocyclic Chemistry, Vol. 33, Núm. 6, pp. 1671-1677

1995

  1. Hypoxia-Selective Agents Derived from 2-Quinoxalinecarbonitrile 1,4-Di-N-oxides. 2

    Journal of Medicinal Chemistry, Vol. 38, Núm. 22, pp. 4488-4494

  2. Hypoxia-Selective Agents Derived from Quinoxaline 1,4-Di-N-oxides

    Journal of Medicinal Chemistry, Vol. 38, Núm. 10, pp. 1786-1792

  3. New hypoxia‐selective cytotoxines derived from quinoxaline 1,4‐dioxides

    Journal of Heterocyclic Chemistry, Vol. 32, Núm. 4, pp. 1213-1217

1994

  1. 3‐Amino‐2‐quinoxalinecarbonitrile. New fused quinoxalines with potential cytotoxic activity

    Journal of Heterocyclic Chemistry, Vol. 31, Núm. 5, pp. 1135-1139

  2. Hypoxia-selective antitumor agents derived from 1,9-diazaanthracene

    European Journal of Medicinal Chemistry, Vol. 29, Núm. 6, pp. 441-445

  3. Synthesis and preliminary cytotoxic activity of dimethoxy‐acridines and dimethoxynitroacridines

    Journal of Heterocyclic Chemistry, Vol. 31, Núm. 6, pp. 1455-1460